USANA Health Sciences USNA Proceeds from acquisition working capital adjustment

Proceeds from acquisition working capital adjustment at other companies

Enerpac Tool GroupEPAC

$0-100%

OomaOOMA

$357K+102%

Nabors IndustriesNBR

$84.43M—

Lesaka Technologies, Inc.LSAK

$2.17M+22.6%

Edwards LifesciencesEW

$0-100%

Corsair Gaming, Inc.CRSR

$260.25K—

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept usna:ProceedsFromAcquisitionOfBusinessWorkingCapitalAdjustmentsProceedsFromAcquisitionWorkingCapitalAdjustment.

The official record: USANA Health Sciences’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's proceeds from acquisition working capital adjustment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's proceeds from acquisition working capital adjustment?: USANA Health Sciences (USNA) reported proceeds from acquisition working capital adjustment of $216.25K in Q4 2025.
What does proceeds from acquisition working capital adjustment mean?: Cash received as a result of post-closing adjustments to the working capital balance of an acquired business. This metric indicates the finalization of purchase price allocations and the accuracy of initial valuation estimates regarding the acquired entity's net assets.